Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds.
General Medicine raises $120 million in Series B funding
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
General Medicine is a healthcare store that allows customers to search, compare and buy care. They can also see insurance and cash prices before selecting their care, and receive guidance from a clinician. The company’s catalog includes more than 2,900 products and services.
The Series B round was led by Andreessen Horowitz (a16z), with participation from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. In total, General Medicine has raised $152 million. The financing will help General Medicine expand its store to include additional categories of care.
Suki raises $90 million in Series E funding
Suki is an ambient clinical intelligence company. Its solutions include ambient documentation, assisted revenue cycle and clinical reasoning. The company serves more than 450 healthcare organizations and supports more than 100 specialties, including cardiology, emergency medicine and family medicine.
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
The Series E round includes participation from Healthier Capital, Crosslink Capital, Hercules Capital, Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures. Dr. Aman Mahajan, partner at Healthier Capital, will join Suki’s board of directors as part of the funding.
Abby Care secures $82 million in Series C funding
Abby Care is an AI-powered care-at-home platform. It helps train and certify family caregivers by pairing them with RN care managers who provide clinical oversight. The company currently operates in eight states and serves thousands of families.
The Series C round was led by Transformation Capital and included participation from CVS Health Ventures, Frist Cressey Ventures, Pivotal Ventures, Khosla Ventures, Thrive Capital and Sequoia Capital. The financing will help Abby Care expand into new markets and invest in AI, clinical research and health plan partnerships.
Baba rakes in $40 million in Series A funding
Baba advocates for patients with Medicare or Medicaid coverage. Each patient has a care team that includes care coordinators and therapists. These care teams help beneficiaries schedule appointments, manage bills and prescriptions, file appeals for care denials and more.
The Series A round was led by FirstMark Capital, with participation from CVS Health Ventures, Valtruis, General Catalyst, Genius Ventures and Ground Up Ventures. The financing will go toward AI research, serving more health plans and accelerating its value-based arrangements.
Photo: DBenitostock, Getty Images